Ritalin LA en es it fr

Ritalin LA Brand names, Ritalin LA Analogs

Ritalin LA Brand Names Mixture

  • No information avaliable

Ritalin LA Chemical_Formula


Ritalin LA RX_link


Ritalin LA fda sheet

Ritalin_LA FDA

Ritalin LA msds (material safety sheet)

Ritalin_LA MSDS

Ritalin LA Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Ritalin LA Molecular Weight

233.306 g/mol

Ritalin LA Melting Point


Ritalin LA H2O Solubility


Ritalin LA State


Ritalin LA LogP


Ritalin LA Dosage Forms

Tablets; Tablets (sustained release)

Ritalin LA Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Ritalin LA Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Ritalin LA Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Ritalin LA side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Ritalin LA Patient Information

Ritalin LA Organisms Affected

Humans and other mammals